PillNilotinib
Brands: Tasigna · Nilotinib
9 active makers
soon
soon
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it9 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Cipla USA Inc. | unknown | 6 | SUPPLYING |
| Novadoz Pharmaceuticals LLC | unknown | 5 | SUPPLYING |
| Novartis Pharmaceuticals Corporation | unknown | 5 | SUPPLYING |
| AvKARE | unknown | 4 | SUPPLYING |
| Torrent Pharmaceuticals Limited | unknown | 4 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 3 | SUPPLYING |
| Apotex Corp. | unknown | 3 | SUPPLYING |
| Exelan Pharmaceuticals, Inc. | unknown | 3 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 18, 2026RECALLRecall (Class III): Nilotinib Capsules, 200 mg per capsule, packaged in cartons, Rx only, Manufactured for: Cipla USA, Inc., 10 Independenc…
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test. — Recalling firm: Cipla USA, Inc. — U.S.A. Nationwide
- Feb 18, 2026RECALLRecall (Class III): Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, M…
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test. — Recalling firm: Cipla USA, Inc. — U.S.A. Nationwide